The pharmaceutical market  cambodia
Upcoming SlideShare
Loading in...5
×
 

The pharmaceutical market cambodia

on

  • 206 views

Pharmaceuticals: KHR718bn (US$178mn) in 2011 to KHR806bn (US$193mn) in 2012; +12.2% in local currency terms and +8.8% in US dollar terms. Growthforecast unchanged from Q312, although we have adjusted ...

Pharmaceuticals: KHR718bn (US$178mn) in 2011 to KHR806bn (US$193mn) in 2012; +12.2% in local currency terms and +8.8% in US dollar terms. Growthforecast unchanged from Q312, although we have adjusted the absolute value following reassessment of the market size.

Statistics

Views

Total Views
206
Views on SlideShare
206
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

The pharmaceutical market cambodia Document Transcript

  • 1. The Pharmaceutical Market: Cambodia Cambodia Pharmaceuticals & Healthcare Report Lacklustre efforts by the government to boost healthcare means that the Cambodia will be the least attractive to pharmaceutical investors as compared to its South East Asian peers as the population are unable to afford new treatments. Over the longer term we expect such trends to change and active participation in the Association of Southeast Asia Nations (ASEAN) Economic Community will boost its attractiveness. Headline Expenditure Projections Pharmaceuticals: KHR718bn (US$178mn) in 2011 to KHR806bn (US$193mn) in 2012; +12.2% in local currency terms and +8.8% in US dollar terms. Growthforecast unchanged from Q312, although we have adjusted the absolute value following reassessment of the market size. Healthcare: KHR2,982bn (US$737mn) in 2011 to KHR3,312bn (US$794mn) in 2012; +11.1% in local currency terms and +7.8% in US dollar terms. Forecast unchanged from Q3 12. MedicalDevices: KHR108bn (US$27mn) in 2011 to KHR118bn (US$28mn) in 2011; +9.8% in local currency terms and +6.6% in US dollar terms. Forecast unchanged from Q3 12. Risk/RewardRating: Cambodia remains last out of the18 key markets in BMI's Q412 Asia Pacific Pharmaceutical Risk/Reward Ratings with a score of 33.5, significantly lower than the regional average of 53.3. Near-term risks includes rampant corruption and poor healthcare provision although its membership in the ASEAN can boost its long-term attractiveness. Competitive Landscape The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors. table Of Contents bmi Industry View 7 swot 9 industry Forecast 11 pharmaceutical Market Forecast 11 table: Pharmaceutical Sales Indicators, 2009-2017 12 healthcare Market Forecast 13 table: Healthcare Expenditure Indicators, 2009-2017 14 table: Healthcare Governmental Indicators, 2009-2017 15 table: Healthcare Private Indicators 2009-2017 15 pharmaceutical Trade Forecast 16 table: Pharmaceutical Trade Indicators, 2009-2017 17 other Healthcare Data 18 industry Risk Reward Ratings 19 table: Asia Pacific Pharmaceutical Risk/reward Ratings, Q213 19 rewards 20 risks 21 market Overview 22 industry Trends And Developments 23 The Pharmaceutical Market: Cambodia
  • 2. epidemiology 23 healthcare Sector 25 health Insurance 27 research & Development 27 clinical Trials 27 regulatory Development 29 regulatory Regime 29 intellectual Property Issues 29 counterfeit Medicines 30 pricing And Reimbursement 32 competitive Landscape 34 pharmaceutical Sector 34 company Developments 36 pharmaceutical Wholesale 37 pharmaceutical Retail 37 company Profile 39 pharmaproduct Manufacturing (ppm) 39 cambodia Pharmaceutical Enterprise - Q1 2013 42 sanofi 44 pfizer 46 demographic Forecast 48 demographic Outlook - Cambodia 48 table: Cambodia's Population By Age Group, 1990-2020 ('000) 49 table: Cambodia's Population By Age Group, 1990-2020 (% Of Total) 50 table: Cambodia's Key Population Ratios, 1990-2020 51 table: Cambodia's Rural And Urban Population, 1990-2020 51 The Pharmaceutical Market: Cambodia
  • 3. glossary 52 methodology 54 methodology 54 risk/reward Ratings Methodology 54 ratings Overview 55 table: Pharmaceutical Business Environment Indicators 55 weighting 56 table: Weighting Of Components 56 sources 56 ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ The Pharmaceutical Market: Cambodia